Here’s How Kareena Kapoor Khan, Alia Bhatt & other Bollywood Celebs Reacted As Government Announces COVID-19 Vaccines For All Above 18
Several Bollywood celebrities like Varun Dhawan, Vicky Kaushal, Ranbir Kapoor, Alia Bhatt, Bhumi Pednekar, Akshay Kumar, Govinda Katrina Kaif, Bappi Lahiri and many more were infected by the Coronavirus in the last few weeks.
The Union Government on Monday announced that everyone above the age of 18 will be eligible to get a vaccine against Covid-19 from May 1. The decision was taken in a meeting chaired by Prime Minister Narendra Modi.
Soon as the news surfaced, several Bollywood stars including Kareena Kapoor Khan, Alia Bhatt, Ananya Panday, Malaika Arora, Huma Qureshi and more took to their respective social media handles to laud the decision.
Check out some of the celebs’ reaction below:
Several Bollywood celebrities like Varun Dhawan, Vicky Kaushal, Ranbir Kapoor, Alia Bhatt, Bhumi Pednekar, Akshay Kumar, Govinda Katrina Kaif, Bappi Lahiri and many more were infected by the Coronavirus in the last few weeks.
The third phase of vaccination, which will start on May 1, aims at liberalised vaccine pricing and scaling up of vaccine coverage. Private Vaccination providers have to transparently declare their self-set vaccination price and the eligibility through this channel would be opened up to all adults everyone above the age of 18.
Vaccine manufacturers are empowered to release up to 50 per cent of their supply to state Governments and in the open market at a pre-declared price. On the other hand, states are empowered to procure additional vaccine doses directly from the manufacturers, as well as open up vaccination to any category of people above the age of 18 for the same.
Vaccination will be provided free of cost to the eligible population as defined earlier which include Health Care Workers (HCWs), Front Line Workers (FLWs) and all people above 45 years of age at Government of India (GoI) vaccination centres.
The division of vaccine supply 50 per cent to GoI and 50 per cent to other than its channel would be applicable uniformly across for all vaccines manufactured in the country.
With inputs from IANS